Phase 1 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and young people aged 5 years old up to (but not including) 18 years old
- People who are able to undergo the trial's sound wave treatment and MRI scans without needing sedation
- People who have been diagnosed with a certain type of cancerous brain tumour located in the upper part of the brain (such as malignant glioma, embryonal tumour including ATRT, or ependymoma)
- People whose brain tumour has come back or continued to grow after at least one course of standard treatment (tumours that have spread to multiple spots are also considered)
- People for whom a medical team has agreed, in a multidisciplinary meeting, that treatment with the chemotherapy drug carboplatin is appropriate
- People with a general health and activity score above 50% on the relevant scale for their age (a lower score caused by movement difficulties from the tumour itself may still be considered)
- People who do not have a dangerous build-up of pressure inside the skull
- People taking steroid medication at a dose of 1mg/kg/day or less
- People whose blood test results show healthy enough levels of white blood cells, platelets, liver function, kidney function, and blood clotting for their age
- People who have no side effects from previous treatments rated at grade 2 or above (confirm with trial site)
- People whose scalp has no unhealed wounds
- People who are covered by health insurance
- Young people aged 15–17 who could become pregnant must have a negative pregnancy test and be using an effective method of contraception
- People (and their parents or legal guardians) who have given written consent to participate
Who may not be able to join:
- People weighing less than 15kg
- People who have significant bleeding inside the tumour, or fluid build-up under the skull on the same side as the tumour
- People who have recently received certain other cancer treatments too close to the start of the trial (specific waiting periods apply depending on the treatment — confirm with trial site)
- People who have had radiotherapy within the last 6 weeks
- People who have been treated for another cancer in the last 5 years
- People who have another serious uncontrolled illness or an active infection
- People with other health conditions that the treating doctor considers would make safe participation difficult
- People whose skull or scalp anatomy (such as skull thickness or very thin skin) could make it unsafe to use the trial device, as judged by the treating doctor
- People who have an implanted heart device (such as a pacemaker or defibrillator), brain stimulator, cochlear implant, or certain metal clips in the brain
- People for whom general anaesthesia is not medically safe
- People for whom MRI scanning is not safe, or who have a known allergy to MRI contrast agents such as gadolinium
- People who have a known allergy or medical condition that makes the use of ultrasound contrast agents unsafe (including certain heart conditions, severe lung blood pressure problems, uncontrolled high blood pressure, or breathing distress — confirm with trial site for the full list)
- People who have a known allergy or hypersensitivity to carboplatin
- People currently being treated with the seizure medications phenytoin or fosphenytoin
- People who have recently received a live attenuated vaccine
- People with significant hearing loss rated at grade 3 or above
- People with a history of problems regulating body temperature
- People for whom regular medical follow-up would not be possible due to geographic, social, or mental health reasons
- People who are pregnant or breastfeeding
- People currently taking blood-thinning medications or drugs that affect platelet function
- People currently taking certain medications that could be harmful to the brain and nervous system if taken within 5 half-lives before the treatment session (including certain sedatives, antihistamines, antipsychotics, and others — confirm with trial site for the full list)
- People taking any other medication that the treating doctor believes could cause brain harm as a result of the trial procedure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kevin BECCARIA, MD, PhD, Assistance Publique - Hôpitaux de Paris
Phone: +33 1 71 39 65 92
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dose limiting toxicity directly linked to US emissions by the SonoCloud-9® (3 transducers); Dose limiting toxicity directly linked to US emissions by the SonoCloud-9®(3 transducers)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.